TCGX Acquisition Corp.

CIK: 2137965•Ticker: TCGX

SPAC Overview

$86.3M
IPO Size
IPO
Current Status
2026
IPO Year

Timeline Progress

About

TCGX Acquisition Corp. is a blank-check company seeking an initial business combination, focusing on healthcare and healthcare-related industries, particularly life sciences and medical technology. It may also pursue a target located in Asia, including Hong Kong or the PRC.

Investment Focus

Healthcare, Biopharmaceuticals, Technology

Geographic Focus

Asia, Hong Kong, People’s Republic of China

Embarc dashboard

What the sponsor registered, what the deal actually priced at, and every 8-K that moved it — unit structure, sponsor promote, and the dated lifecycle events, each linked to its filing.

  • Unit structure as registered and as priced — price, warrant coverage, rights, trust per unit
  • Sponsor promote: founder shares and percentage, private-placement warrants, trust deposit
  • The full 8-K lifecycle timeline, each event linked to its filing
  • Price history across the unit, share and warrant tickers
  • Follow it, and see it change on your watchlist
Open in the dashboard

SPAC Team

Sponsors

Underwriters

Extended Team Information

Led by Chen Yu, a healthcare investor and TCGX founder with more than two decades of healthcare investing, company-building and operating experience. The TCGX-affiliated team brings science-driven healthcare investment experience, including substantial experience in China.

Stock Performance

TCGX
Trading Symbol
First Trade
August 6, 2026
$10.65
Current Price
October 1, 2026
$12.25
+15%

Key Information

IPO Date
August 6, 2026
State of Incorporation
E9
SIC
6770
SPAC Ticker
TCGX